2011Anhui Medical and Pharmaceutical JournalRequires access

Clinical application of Amiodarone combined with Irbesartan on treatment in paroxysmal atrial fibrillation patients

XU Ai-qin

Open publisher page 0 citations

Abstract

Aim To observe the effect of Amiodarone combined with Irbesartan treating paroxysmal atrial fibrillation.Method From May 2008 to May 2010,83 paroxysmal atrial fibrillation patients were enrolled and randomly divided into treatment group and control group.The treatmrent group was treated with Amiodarone and Irbesartan,and the control group only with Amiodarone.All the patients had been observed for 12 months.Results The sinus rhythm maintenance rate in treatment group was higher than that in control group and the atrial diameter decreased remarkably in treatment group than in control group(P0.05).Conclusion Irbesartan can inhibit electronic and anatomical remodeling of atrial,reduce the recurrence rate of atrial fibrillation,prevent persistence of atrial fibrillation and maintain the sinus rhythm rate more effectively than Amiodarone only,and it can also inhibit the increase of the left atrial diameter.

About this research paper

What this paper is about

Aim To observe the effect of Amiodarone combined with Irbesartan treating paroxysmal atrial fibrillation.Method From May 2008 to May 2010,83 paroxysmal atrial fibrillation patients were enrolled and randomly divided into treatment group and control group.The treatmrent group was treated with Amiodarone and Irbesartan,and the control group only with Amiodarone.All the patients had been observed for 12 months.Results The sinus rhythm maintenance rate in treatment group was higher than that in control group and the atrial diameter decreased remarkably in treatment group than in control group(P0.05).Conclusion Irbesartan can inhibit electronic and anatomical remodeling of atrial,reduce the recurrence rate of atrial fibrillation,prevent persistence of atrial fibrillation and maintain the sinus rhythm rate more effectively than Amiodarone only,and it can also inhibit the increase of the left atrial diameter.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To observe the effect of Amiodarone combined with Irbesartan treating paroxysmal atrial fibrillation.Method From May 2008 to May 2010,83 paroxysmal atrial fibrillation patients were enrolled and randomly divided into treatment group and control group.The treatmrent group was treated with Amiodarone and Irbesartan,and the control group only with Amiodarone.All the patients had been observed for 12 months.Results The sinus rhythm maintenance rate in treatment group was higher than that in control group and the atrial diameter decreased remarkably in treatment group than in control group(P0.05).Conclusion Irbesartan can inhibit electronic and anatomical remodeling of atrial,reduce the recurrence rate of atrial fibrillation,prevent persistence of atrial fibrillation and maintain the sinus rhythm rate more effectively than Amiodarone only,and it can also inhibit the increase of the left atrial diameter.

Key concepts: Amiodarone, Irbesartan, Medicine, Atrial fibrillation, Sinus rhythm, Cardiology, Internal medicine, Paroxysmal atrial fibrillation

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical application of Amiodarone combined with Irbesartan on treatment in paroxysmal atrial fibrillation patients — Research Paper | ScholarLens